TREATMENT PATTERNS AND OUTCOMES IN METASTATIC COLORECTAL CANCER (MCRC) PATIENTS TREATED IN A COMMUNITY ONCOLOGY SETTING

被引:0
|
作者
Cartwright, T. H. [1 ]
Pan, I [2 ]
Wen, L. [3 ]
Wadlow, R. C. [4 ]
Rembert, D. [5 ]
Seal, B. [6 ]
机构
[1] Mckesson Specialty Hlth, Ocala, FL USA
[2] Mckesson Specialty Hlth, Conroe, TX USA
[3] Bayer HealthCare Pharmaceut Inc, Pine Brook, NJ USA
[4] Mckesson Specialty Hlth, Fairfax, VA USA
[5] Mckesson Specialty Hlth, The Woodlands, TX USA
[6] Bayer HealthCare Pharmaceut Inc, White House Stn, NJ USA
关键词
D O I
10.1016/j.jval.2014.03.407
中图分类号
F [经济];
学科分类号
02 ;
摘要
PCN12
引用
收藏
页码:A69 / A70
页数:2
相关论文
共 50 条
  • [21] Real-world treatment patterns and outcomes associated with bevacizumab (bev) in metastatic colorectal cancer (mCRC).
    Saverno, Kimberly
    Walker, Mark S.
    Hennessy, Daniel
    Dhawan, Ravinder
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [22] Treatment Patterns and Clinical Outcomes Among Metastatic Non-Small-Cell Lung Cancer Patients Treated in the Community Practice Setting
    Nadler, Eric
    Espirito, Janet L.
    Pavilack, Melissa
    Boyd, Marley
    Vergara-Silva, Andrea
    Fernandes, Ancilla
    CLINICAL LUNG CANCER, 2018, 19 (04) : 360 - 370
  • [23] Treatment Patterns Among Patients with EGFRm NSCLC Treated in the US Community Oncology Setting
    Nadler, E.
    Pavilack, M.
    Clark, J.
    Espirito, J.
    Fernandes, A.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S601 - S601
  • [24] Treatment and outcomes of patients with metastatic colorectal cancer (mCRC) with epidermal growth factor receptor (EGFR) therapy in the third-line setting
    Ho, Maria Yi
    Renouf, Daniel John
    Cheung, Winson Y.
    Zhou, Chen
    Goktepe, Ozge
    Lim, Howard John
    Kennecke, Hagen F.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (04)
  • [25] Treatment patterns and outcomes among patients with metastatic melanoma treated in community practice
    Walker, Mark S.
    Reyes, Carolina
    Kerr, Jiandong
    Satram-Hoang, Sacha
    Stepanski, Edward J.
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2014, 53 (11) : E499 - E506
  • [26] Circulating microRNAs in metastatic colorectal cancer (mCRC) patients (pts) treated with regorafenib
    Schirripa, M.
    Loupakis, F.
    Cremolini, C.
    Poliseno, L.
    Salvatore, L.
    Tuccoli, A.
    Antoniotti, C.
    D'Aurzio, R.
    Marmorino, F.
    Borelli, B.
    Rossini, D.
    Saettini, A.
    Gini, S.
    Moretto, R.
    Rizzo, I.
    Aquila, E. Dell'
    Pellegrini, M.
    Falcone, A.
    ANNALS OF ONCOLOGY, 2015, 26
  • [27] Circulating microRNAs in metastatic colorectal cancer (mCRC) patients (pts) treated with regorafenib
    Antoniotti, C.
    Loupakis, F.
    Schirripa, M.
    Cremolini, C.
    Poliseno, L.
    Salvatore, L.
    Tuccoli, A.
    D'Aurizio, R.
    Marmorino, F.
    Borelli, B.
    Rossini, D.
    Saettini, A.
    Gini, S.
    Moretto, R.
    Rizzo, I.
    Dell'Aquila, E.
    Pellegrini, M.
    Falcone, A.
    ANNALS OF ONCOLOGY, 2015, 26 : 37 - 38
  • [28] Skin toxicity in elderly patients with metastatic colorectal cancer (mCRC) treated with Cetuximab
    Jehn, C.
    Stenzel, L.
    Boening, L.
    Kroening, H.
    Possinger, K.
    Lueftner, D.
    ONKOLOGIE, 2010, 33 : 175 - 176
  • [29] Treatment of elderly patients with metastatic colorectal cancer (MCRC): Our experience
    Longo, F.
    Proietti, E.
    Raimondi, C.
    Graziano, V
    Zivi, A.
    Sacco, P.
    Cerbone, I
    Russillo, M.
    Restuccia, M.
    di Seri, M.
    ANNALS OF ONCOLOGY, 2006, 17 : 74 - 74
  • [30] Treatment Patterns and Clinical Outcomes in Patients With Metastatic Gastroenteropancreatic Neuroendocrine Tumors Treated in the Community Practice Setting in the United States
    Jiao, Xiaolong
    Pulgar, Sonia
    Boyd, Marley
    Braiteh, Fadi
    Mirakhur, Beloo
    Lowenthal, Susan Pitman
    Fox, Patricia
    Frytak, Jennifer
    Cox, David
    Paulson, A. Scott
    PANCREAS, 2018, 47 (02) : 173 - 182